Chad J. Kolean - 24 Feb 2022 Form 3/A - Amendment Insider Report for Cellectar Biosciences, Inc. (CLRB)

Role
Chief Financial Officer
Signature
/s/ Christina Blakley, Attorney-in-fact for Chad Kolean
Issuer symbol
CLRB
Transactions as of
24 Feb 2022
Net transactions value
$0
Form type
3/A - Amendment
Filing time
15 Apr 2022, 17:00:39 UTC
Date Of Original Report
24 Feb 2022
Previous filing
24 Feb 2022
Next filing
18 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CLRB Common Stock 240 24 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment to Form 3 is being filed to report the Reporting Person's direct ownership of 240 shares of Common Stock, which were inadvertently omitted from his Form 3 filed February 24, 2022.